Skip to main content

The Impact of COVID-19 on Lung Cancer Patients

New Content ItemThe global COVID-19 pandemic has led to changes in public health measures causing significant disruption across lung cancer screening, diagnosis, treatment and management pathways. The pandemic has presented many challenges for lung cancer patients. These measures have also impacted people's behaviour and their interaction with the healthcare system. Therefore, increased knowledge of the broader as well as biological impacts of COVID-19 on lung cancer patients' health, is required.

To help address this need, BMC Pulmonary Medicine has published this collection to bring together research on:

  • characterizing the interaction of COVID-19 and lung cancer, 
  • health-related behavior changes impacting lung cancer patients,
  • the effect of changes to lung cancer care pathways,
  • and the long term impact of the pandemic on lung cancer patients. 

We also encouraged submissions discussing what we can learn from the pandemic to help build a better future for lung cancer research and care.

Meet the Guest Editors

Asst. Prof. Michele Mondoni

New Content Item

Michele Mondoni is an Assistant Professor of Respiratory Medicine at the University of Milan, and works within the Pulmonology Unit of ASST Santi Paolo e Carlo. He graduated from the University of Milan in 2002 and received his II Level Master Degree in Interventional Pulmonology and Pulmonary Immunopathology at the University of Parma in 2011. His main areas of expertise are interventional pulmonology and interstitial lung diseases. His research interests include clinical and interventional pulmonology and ILDs. He joined the Editorial Board of BMC Pulmonary Medicine in 2018 and is Senior Editorial Board Member since 2020. 

Dr Jian Wu

New Content Item

Dr Jian Wu works within the State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University. Dr Wu 's research interests include the biological effects and clinical outcomes of COVID-19 on patients.

  1. The COVID-19 pandemic has had negative drawbacks on the healthcare system worldwide and on individuals other than those directly affected by the virus. Delays in cancer therapy and diagnosis have been reported...

    Authors: Thomas S. Tarawneh, Elisabeth K. M. Mack, Charis Faoro, Andreas Neubauer, Martin Middeke, Andreas Kirschbaum and Angélique Holland
    Citation: BMC Pulmonary Medicine 2024 24:320
  2. Bronchoscopy is a useful technique adopted in the management of patients with COVID-19. 10–40% of COVID-19 survivors experience persistent symptoms. A comprehensive description of the utility and safety of bro...

    Authors: Michele Mondoni, Rocco Francesco Rinaldo, Jacopo Cefalo, Laura Saderi, Beatrice Vigo, Paolo Carlucci, Claudio Tirelli, Umberto Cariboni, Pierachille Santus, Stefano Centanni and Giovanni Sotgiu
    Citation: BMC Pulmonary Medicine 2023 23:178